NSE: UPL | BSE: 512070 | ISIN: INE628A01036

INDUSTRY : Agrochemicals

UPL Ltd.

Await Turnaround

391.10 3.30 (0.85%)

44.84% Fall from 52W High

Volume: 9.3M

NSEMay 28, 2020 15:31

Check Buy or Sell



UPL Ltd.    
28 May 2020, 06:36PM
391.10
0.85%
default
UPL Ltd.    
26 May 2020
391.10
0.85%
UPL shares rise 4% as brokerages retain positive view after Q4 earnings
UPL shares rise 4% as brokerages retain positive view after Q4 earnings
Moneycontrol
CLSA also retained its buy rating on UPL with a target at Rs 500 per share as Q4 revenue was 11 percent ahead of its estimates and key markets saw healthy revenue growth led by volume market share gains, though weak gross margin led to an EBITDA miss.
UPL Ltd.    
26 May 2020
391.10
0.85%
Nirmal Bang Institutional
UPL 4QFY20 results were a significant beat vs NBIE estimates Consolidated adjusted PAT came in at Rs7.88bn vs our estimate of Rs2.4bn and Bloomberg estimate of Rs8.8bn. The beat on revenue was driven by significantly positive volume growth across LatAm, US and RoW bucking the COVID-19 related disruption, which underpinned our degrowth assumptions. Margins however were a miss - gross margin stood at 44% vs our estimate of 47%, while EBITDA margin came in at 17.1% vs our estimate of 17.9%. We have raised earnings by 6.3%/20.8% for FY21E/FY22E based on upbeat commentary on growth and margin expansion by UPL management during earnings call. Management also expects to monetize the R&D; pipeline on...
UPL Ltd. has an average target of 555.50 from 8 brokers.
UPL Ltd.    
23 May 2020
391.10
0.85%
Prabhudas Lilladhar
We have upgraded our topline/EBITDA/APAT by 3%/3.6%/11% for FY21E and 2.6%/0.6%/5.8% for FY22E but lowered our target price from Rs542 to Rs497 based on 7.0x FY22E EV/EBITDA (implied P/E on TP- 11x) due to lower than expected debt reduction (considering perpetual bond as part of debt). UPL...
UPL Ltd. is trading below it's 100 day SMA of 455.0
UPL Ltd.    
23 May 2020
391.10
0.85%
BOB Capital Markets Ltd.
UPL's Q4 EBITDA was below our estimate at Rs 19bn as stronger revenue growth was offset by gross margin pressure and higher forex loss.
UPL Ltd. has lost -32.56% in the last 6 Months
UPL Ltd.    
23 May 2020
391.10
0.85%
buy
Neutral: UPL Ltd.
Motilal Oswal
On like-to-like basis (i.e. including Arysta in 4QFY19), revenue grew 26% YoY Note that EBITDA growth of 25% in 4QFY20 was driven by cost and revenue synergies; excluding the same, EBITDA remained flat (refer For FY20, like-to-like revenue/EBITDA grew 13%/18%; revenue growth was driven by 16% volume growth, offset by 1% decline in prices and 2% forex In 4QFY20, strong revenue growth was witnessed across regions (North According to management, for 4QFY20/FY20, cost synergy realized from the Arysta acquisition stood at INR2.4b/INR7.7b and revenue synergies at Draft proposal on banning 27 pesticides in India would not impact the Cost synergy of USD150m, revenue synergy of USD200m and UPLL is aiming to reduce Net Debt to EBITDA to 2x by FY21 from 2.9x as at UPLLs FY20 revenue/EBITDA (like-to-like) grew 13%/18%, primarily driven by synergy benefits; excluding the same, base business (UPLL and Arysta; ex-synergy) operating performance remained flat (refer Additionally, net debt reduced by INR44b in FY20 (in line with guidance).
UPL Ltd. is trading below it's 100 day SMA of 455.0
UPL Ltd.    
22 May 2020
391.10
0.85%
UPL Q4 net profit more than doubles to Rs 617 crore
UPL Q4 net profit more than doubles to Rs 617 crore
Moneycontrol
Total income rose to Rs 11,162 crore during the quarter under review as compared with Rs 8,573 crore in the corresponding period of the previous year.
UPL Ltd.    
22 May 2020
391.10
0.85%
UPL Limited - 512070 - Announcement under Regulation 30 (LODR)-Change in Directorate
BSE India
We would like to inform you that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held today i.e. 22nd May 2020 has recommend to the members of the Company the re-appointment of Dr. Vasant Gandhi (DIN: 00863653) as an Independent Director of the Company for a second term of five (5) consecutive years w.e.f. 23rd November 2020. The current tenure of Dr. Vasant Gandhi as an Independent Director is completing on 22nd November 2020. The proposal will be considered by the members of the Company at the ensuing Annual General Meeting. Dr. Vasant Gandhi is not related inter-se to any director of the Company. He is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. Brief profile of Dr. Vasant Gandhi is attached. We request you to take the above information on records.
UPL Ltd.    
22 May 2020
391.10
0.85%
UPL Ltd.    
22 May 2020
391.10
0.85%
  • Nirmal Bang Institutional increased Buy price target of UPL Ltd. to 643.0 on 26 May, 2020.
  • Stock Price (366.8) crossed above 30 Day SMA (360.69) on 21 May, 2020
  • Stock Price (366.8) crossed above 50 Day SMA (361.28) on 21 May, 2020
  • Month Change by 28.65% (Crossed threshold 20%) on 30 April, 2020
  • Week Change by 25.07% (Crossed threshold 20%) on 30 April, 2020
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
May 28, 20198.00FINALMay 29, 2019
Aug. 9, 20188.00FINAL-
June 22, 20177.00FINAL-
June 16, 20165.00FINAL-
July 16, 20155.00FINAL-
All dividends by UPL
Ex-Date Dividend Bonus Ratio Record Date
July 2, 20191:2July 3, 2019
Oct. 29, 20081:1Oct. 31, 2008
All bonuses by UPL
Ex-Date Dividend Old FVNew FV Record Date
Sept. 27, 2005102Oct. 5, 2005
All splits by UPL